An iconic symbol of Easter, the PEEPS® brand has been the Easter basket staple for just over 60 years. With more than 1.5 billion PEEPS® consumed during Easter alone, it’s no wonder PEEPS® have remained the #1 non-chocolate candy at Easter for more than 20 years. From making colorful additions to baked goods, to decorative accents for craft and art projects, to fun little surprises hidden inside Easter eggs or simply savoring the sweet treat on its own, PEEPS® are sure to bring a smile to kids of all ages.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65392-just-born-easter-basket-favorite-peeps-offers-variety-for-everyone
Just Born Quality Confections, the makers of iconic candy brands such as PEEPS®, MIKE AND IKE®, HOT TAMALES® and GOLDENBERG’S® PEANUT CHEWS® is excited to announce that the one and only Energizer Bunny™ has been selected as the new PEEPS® Celebrity Creative Director. The Pink PEEPS® Bunny searched far and wide to find the perfect creative partner to help drum up new energy for the 2018 Easter product line. With his power-packed, unstoppable nature, the Energizer Bunny™ was the best choice for the job.
“It’s no surprise that Easter is THE holiday for PEEPS®, and after 65 years we needed ‘some -bunny’ to help re-energize the brand’s product offerings and help us power up innovation,” said the Pink PEEPS® Bunny, Director of Bunny Operations (via translator.) “Who better to help power up innovation than the coolest symbol of long-lasting energy – the Energizer Bunny™, plus he kind of looks like me!”
To view the multimedia release go to:
https://www.multivu.com/players/English/8288951-peeps-energizer-bunny-easter-creative-director/
Could migraine patients be doing more to get the most out of their medical visits? According to a new national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline, the answer is yes. For the nearly 30 million migraine sufferers in the U.S., including six million treating with prescription medication, these survey results may have important implications.
The survey, conducted online in November 2010 by Harris Interactive, included 1,218 diagnosed migraine patients taking prescription medications for their migraine attacks as well as 533 physicians who treat between five and 10 migraine patients per week. The findings revealed disparities between what patients and physicians each reported typically discussing during office visits.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/glaxosmithkline/48596/
http://yourinnerpower.com.au/ - David Wilson an alcohol & cocaine addict, came to Your Inner Power 6 months ago to help him get rid of his addiction. Jackie Durnin used EFT Tapping technique to treat his addiction. Visit us to know more!
The Procter & Gamble Company (NYSE: PG) support for the relief and rebuilding efforts in Haiti now totals over $2 million.
P&G product donations total more than $1.2 million with cash and donations from P&G, its employees and retirees, taking the total over $2 million. Product donations include bar soaps, batteries, bleach, diapers, dish detergents, feminine hygiene products, flashlights, laundry detergents, paper towels, shampoos, toilet tissue, tooth brushes, toothpaste, and wipes. Additionally, P&G has committed to providing six million packets of PUR, a technology that purifies contaminated water. This quantity is enough to treat 60 million liters of water (a 3-month supply for 340,000 people).
To view Multimedia News Release go to, http://multivu.prnewswire.com/mnr/pg/42295/
OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional™ nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex® nasal spray (AUC 0-15 = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The OptiNose technology achieved this improved effect despite delivering 20% less drug into the nose (16mg) than the Imitrex® liquid nasal spray (20mg).
To view Multimedia News Release, go to http://www.multivu.com/players/English/57713-optinose-innovative-breath-powered-nasal-delivery-technology-delivers-drugs-to-treat-variety-of-medical-conditions
Every spring, allergies take control of the lives of millions of Americans, affecting their work, their family time and even how well they sleep at night. Something else affects those millions of allergy sufferers, according to a new survey: big misconceptions about allergies that may keep people from getting needed relief.
To help put those misconceptions about allergies to rest, Sanofi is teaming up with science educator and television personality Adam Savage, along with allergist Dr. Neeta Ogden, to dispel them with credible information. The goal: help the 50 million allergy sufferers in America get the facts they need to understand and treat their allergies and take back control of their lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8255452-sanofi-allergy-misconceptions-facts-adam-savage/
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
Calling all cheesecake fanatics! Fiber One is introducing the perfect treat to satisfy cheesecake cravings any time with new Fiber One Cheesecake Bars in Salted Caramel and Strawberry. In honor of the new, guilt-free treat, Fiber One is turning National Cheesecake Day – July 30 – into a month-long cheesecake celebration. The brand kicked off the celebration with a pop-up Cheesecake Café sampling event at Grand Central Station, in New York City on National Cheesecake Day. The cheesecake celebration will continue throughout August 2015, when Fiber One will host its own Cheesecake Appreciation Month Sweepstakes* and a partnership with Hungry Girl to give tips on guilt-free ways to indulge in the dessert.
“We are excited to introduce a guilt-free option inspired by a classic American dessert,” said Maria Lopez, associate marketing manager. “Fiber One Cheesecake Bars have cheesecake taste and texture that fulfill cheesecake cravings. This new offering is definitely worth celebrating throughout August and beyond.”
With five grams of fiber and 150 calories per individually packaged bar, Fiber One Cheesecake Bars are the perfect guilt-free dessert with the added benefit of fiber. The irresistible layers of graham cracker-y goodness and creamy cheesecake allow you to indulge in a sweet treat without fighting your instincts to fill your cheesecake cravings
To view the multimedia release visit:
http://www.multivu.com/players/English/7551251-fiber-one-cheesecake-bars/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
All of us will experience hair loss as we age. The rate at which we do will dependent on what you put on our hair and how you treat it. Do you treat it as an asset, or it just something that gets in your way? Well, treat your hair like a Queen or King, and the longer you will have it.
http://www.miraclemulti.com MiracleMulti™ The Best Multivitamins on the market for Men, Women, Vegetarians, and Bodybuilding. Once a day Multivitamin for Health, Energy, Focus, Well Being and Anti-aging.***These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
